logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hisao Imai

Saitama Medical University
H指数:38
被引数:5,231

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Outcomes and Early Progressive Disease Analysis of Nivolumab and Ipilimumab Combination Therapy in Metastatic NSCLC: LIGHT-NING Study 2.5-year update

真实世界结局和早期进展性疾病分析：纳武利尤单抗联合伊匹木单抗治疗转移性非小细胞肺癌的LIGHT-NING研究2.5年更新

Clinical Lung Cancer
IF3.3
2026-10-130
OAAI
Hisao Imai; Teppei Yamaguchi; Koichi Azuma; Takashi Kijima; Yukihiro Toi; Kazuma Kishi; Kohei Fujita; Haruhiro Saito; Yoshimasa Shiraishi; Junko Tanizaki; Yuta Takashima; Yuichi Tambo; Satoshi Watanabe; Osamu Hataji; Tatsuro Fukuhara; Tomoyuki Ohsugi; Yu Tobishima; Hidehito Horinouchi
The CD4+ T cell population partners with Tpex CD8+ T cells to mediate antitumor immunity in the tumor microenvironment

CD4+ T细胞群体与Tpex CD8+ T细胞协同作用，以介导肿瘤微环境中的抗肿瘤免疫。

Nature Communications
IF15.7
2026-03-280
OA
Shota Takei; Satoshi Yamasaki; Ou Yamaguchi; Atsuto Mouri; Ayako Shiono; Yu Miura; Kosuke Hashimoto; Hisao Imai; Kyoichi Kaira; Yoshinobu Ichiki; Hiroyuki Nitanda; Hirozo Sakaguchi; Tomoyuki Hishida; Katsuhisa Horimoto; Hiroshi Kagamu
Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529)
RADIATION ONCOLOGY
IF3.2
2025-01-040
OAAI
Tokito, Takaaki; Yamada, Kazuhiko; Ishii, Hidenobu; Takiguchi, Yuichi; Saito, Go; Minato, Koichi; Imai, Hisao; Tanaka, Hiroshi; Miura, Satoru; Watanabe, Kageaki; Koreeda, Yoshifusa; Ono, Akira; Furuya, Naoki; Misumi, Toshihiro; Hayakawa, Kazushige; Ogo, Etsuyo; Okamoto, Hiroaki
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
TARGETED ONCOLOGY
IF4
2024-04-133
OAAI
Nishioka, Naoya; Imai, Hisao; Endo, Masahiro; Notsu, Akifumi; Doshita, Kosei; Igawa, Satoshi; Yokouchi, Hiroshi; Ninomiya, Takashi; Tokito, Takaaki; Soda, Sayo; Fujiwara, Takasato; Asao, Tetsuhiko; Nakamichi, Shinji; Kawamura, Takahisa; Inomata, Minehiko; Nakashima, Kazuhisa; Ito, Kentaro; Goto, Yasuhiro; Umeda, Yukihiro; Hirai, Soichi; Ushio, Ryota; Yokoo, Keiki; Takeda, Takayuki; Fukui, Tomoya; Ishihara, Masashi; Osaki, Takashi; Kubo, Sousuke; Fujiwara, Takumi; Yamamoto, Chie; Tsuda, Takeshi; Tamura, Nobumasa; Hosokawa, Shinobu; Chihara, Yusuke; Ikeda, Satoshi; Furuya, Naoki; Nakahara, Yoshiro; Miura, Satoru; Okamoto, Hiroaki
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study)
CLINICAL CANCER RESEARCH
IF10.2
2024-01-021
OAAI
Nakamichi, Shinji; Kubota, Kaoru; Misumi, Toshihiro; Kondo, Tetsuro; Murakami, Shuji; Shiraishi, Yoshimasa; Imai, Hisao; Harada, Daijiro; Isobe, Kazutoshi; Itani, Hidetoshi; Takata, Saori; Wakui, Hiroshi; Misumi, Yuki; Ikeda, Satoshi; Asao, Tetsuhiko; Furuya, Naoki; Hosokawa, Shinobu; Kobayashi, Yumiko; Takiguchi, Yuichi; Okamoto, Hiroaki
LIGHT-NING 2nd interim analysis: Early safety of 1L nivolumab plus ipilimumab plus /- chemotherapy for NSCLC in Japan
ANNALS OF ONCOLOGY
IF65.4
2023-11-011
OA
Azuma, Koichi; Imai, Hisao; Kijima, Takashi; Kishi, Kazuma; Saito, Haruhiro; Yamaguchi, Teppei; Hayashi, Hidetoshi; Shiraishi, Yoshimasa; Fujita, Kohei; Watanabe, Satoshi; Kitazono, Satoru; Fukuhara, Tatsuro; Hataji, Osamu; Toi, Yukihiro; Mizutani, Hideaki; Hamakawa, Yusuke; Maemondo, Makoto; Ohsugi, Tomoyuki; Suzuki, Keisuke; Horinouchi, Hidehito; Ohe, Yuichiro
OSIRAM-1: A multicenter, open label, randomized phase II study of osimertinib plus ramucirumab versus osimertinib alone as initial chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer (TORG1833)
ANNALS OF ONCOLOGY
IF65.4
2023-10-012
PRE
Nakahara, Y.; Kato, T.; Isomura, R.; Misumi, T.; Tamiya, M.; Yoh, K.; Furuya, N.; Ono, A.; Takiguchi, Y.; Koyama, K.; Ikeda, S.; Watanabe, K.; Tokito, T.; Seki, N.; Imai, H.; Shukuya, T.; Shibata, Y.; Hosokawa, S.; Kozuki, T.; Okamoto, H.

研究方向

暂未获取到该数据
K
Kyoichi Kaira
H 指数:54论文数:687被引数:1.2万
H
Hiroshi Kagamu
H 指数:32论文数:348被引数:4,101
A
Ayako Shiono
H 指数:17论文数:113被引数:1,167
O
Ou Yamaguchi
H 指数:27论文数:168被引数:2,514
N
Noriaki Sunaga
H 指数:42论文数:224被引数:5,905
A
Atsuto Mouri
H 指数:17论文数:154被引数:1,023
T
Tamotsu Ishizuka
H 指数:49论文数:296被引数:6,880
M
Masatomo Mori
H 指数:58论文数:711被引数:1.1万
K
Keita Mori
H 指数:44论文数:372被引数:6,438
A
Akira Ono
H 指数:36论文数:296被引数:4,769